About Angiex
Angiex is a private company based in Cambridge, Massachusetts. It has reported $24,871,717 raised in two offerings on Form D since July 2017. Its chief executive is Paul Jaminet.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 2025 | Aug 14, 2025amended Sep 26, 2025 | $21,991,695of $28.4M target | 137 | $160K | Equity, Options, Securities on exerciseRule 506(c) | Form D/A ↗1 earlier filing |
| Jul 3, 2017 | Jul 17, 2017 | $2,880,022of $3.0M target | 3 | $960K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $24,871,717 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Angiex's Form D filed Sep 26, 2025.
JA
Jonathan Adams
Director
Errik Anderson
Director
Also a director at Aakha Biologics and a founder, CEO, chairman of alloy at Alloy Therapeutics.
JC
FH
PJ
Paul Jaminet
Chief Executive Officer and director
AA
Amal Amin
Director
HG
Haijing Guo
Director
ID
Iain Dukes
Director
TN
Tina Neel
Director